Soluble herpesvirus glycoprotein complex vaccine

Details Soluble herpesvirus glycoprotein complex vaccine Soluble herpesvirus glycoprotein complex vaccine

1997-07-31

2000-12-05

Mosher, Mary E.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Conjugate or complex

4242311, 4241861, 536 2372, A61K 39245, C12M 1538

Patent

active

061563196

ABSTRACT:
The invention is directed to a herpes simplex virus vaccine comprising a herpes simplex virus glycoprotein H-glycoprotein L complex. The invention is also directed to a vaccine comprising a DNA encoding a herpes simplex virus glycoprotein H-glycoprotein L complex. Also included is an antibody which specifically binds to a herpes simplex virus glycoprotein H-glycoprotein L complex and DNA encoding the same.

REFERENCES:
patent: 4053585 (1977-10-01), Allison et al.
patent: 4082735 (1978-04-01), Jones et al.
patent: 4082736 (1978-04-01), Jones et al.
patent: 4101536 (1978-07-01), Yamamura et al.
patent: 4185089 (1980-01-01), Derrien et al.
patent: 4235771 (1980-11-01), Adam et al.
patent: 4261975 (1981-04-01), Fullerton et al.
patent: 4291019 (1981-09-01), Lupton et al.
patent: 4406890 (1983-09-01), Tarrsay et al.
patent: 4606918 (1986-08-01), Allison et al.
patent: 4661349 (1987-04-01), Kino et al.
patent: 4689225 (1987-08-01), Pereira
patent: 5149529 (1992-09-01), Ho et al.
patent: 5224792 (1993-07-01), Burke et al.
patent: 5474914 (1995-12-01), Spaete
McKenzie et al, Advances in Experimental Medicine and Biology 394:67-83, 1996.
Mester, et al., 1991, Reviews of Infectious Diseases, 13:5935-5945.
Andersson et al., 1989, J. of Biological Chemistry, 264:8222-8229.
Blochlinger et al., 1984, Molecular and Cellular Biology, 4:2929-2931.
Cines et al., 1982, J. Clin. Invest., 69:123-128.
Cohen et al., 1986, J. of Virol., 60:157-166.
Cranage et al., 1988, J. of Virol., 62:1416-1422.
Davison et al., 1986,J. Gen. Virol., 67:1759-1816.
Desai et al., 1988, J. Gen. Virol., 69:1147-1156.
Farrell et al., 1994, J. Virol., 68:928.
Foa-Tomasi et al., 1991, Virol., 180:474-482.
Forrester et al., 1992, J. of Virol., 66:341-348.
Friedman et al., 1989, Molecular andCellular Biology, 9:2303-2314.
Fuller et al., 1989, J. of Virol., 63:3435-3443.
Gompels et al., 1986, Virol., 153:230-247.
Gompels et al., 1988, J. Virol., 69:2819-2829.
Gompels et al., 1989, J. of Virol., 63:4744-4755.
Graham et al., 1973, Virol., 52:456-467.
Josephs et al., 1991, J. of Virol., 65:5597-5604.
Kaye et al., 1992, J. of Gen. Virol., 73:2693-2698.
Klupp et al., 1991, Virol., 182:732-741.
McGeoch et al., 1986, Nucleic Acids Research, 14:4281-4292.
McGeoch et al., 1988, J. Gen. Virol., 69:1531-1574.
Peeters et al., 1992, J. Virol., 66:3888-3892.
Shawalter et al., 1981, Infection of Immunity, 34:684-692.
White, 1992, Science, 258:917-924.
Ghiasi et al., 1994, J. Virol., 68-4: 2118-2126.
Roop et al., 1993, J. Virol., 67-4:2285-2297.
Ghiasi et al., 1992, J. Gen. Virol., 73:719-722.
Gompels et al., 1991, J. Virol., 65:2393-2401.
Ghiasi et al., 1991, Virol., 185:187-194.
Roberts et al., 1991, Virology, 184:609-624.
Buckmaster et al., 1984, Virology, 139:408-413.
Fuller et al., 1989, J. Virol., 63-8:3435-3443.
Browne et al., 1993, J. Gen. Virol. 74:2813-2817.
Spaete et al., 1993, Virol., 193:853-861.
Yaswen et al., 1993, Virol., 195:387-396.
Hutchinson et al., 1992, J. Virol., 66:2240-2250.
Liu et al., 1993, J. Gen. Virol., 74:1847-1857.
Liu et al., 1993, Virol. 197:12-22.
Burton et al., 1994, Adv. Immunol. 57:191-280.
Davis-Poynter et al, 1994, J. Virol. 68:7586-7590.
Dubin et al. 1995, J. Virol. 69:4564-4568.
Eisenberg et al., 1987, Microb. Pathog. 3:423-435.
Eisenberg et al., 1982, J. Virol. 41:1099-1104.
Forrester et al., 1991, J. Gen. Virol. 72:369-375.
Friedman et al., 1989, Mol. Cell. Biol. 9:2302-2314.
Goldstein et al., 1988, J. Virol. 62:2970-2977.
Highlander et al., 1987, J. Virol. 61:3356-3364.
Johnson et al., 1990, J. Virol. 64:2569-2576.
Ligas et al., 1988, J. Virol. 62-1486.
Montgomery et al., 1996, Cell. 87:427-436.
Nicola et al., 1997, J. Virol. 71:2940-2946.
Nicola et al., 1996, J. Virol. 70:3815-3822.
Novotny et al., 1996, Virology 221:1-13.
Sambrook et al., 1989, Molecular Clonining: A Laboratory Manual, Colg Spring Harbor, NY, pp. 16.14, 16.30 and 16.31.
Simmons et al., 1985, J. Virol. 53:944-948.
Simmons et al., 1984, J. virol. 52:816-821.
Sisk et al., 1994, J. Virol. 68:766-775.
Stanberry, Pathogenesis of herpes simplex virus infection and animal models for its study. In: Current Topics in Microbiology and Immunology, 179: Herpes simplex virus: Pathogenesis and Control, Springer Verlag (Berlin), 1992, pp. 15-30.
Tal-Singer et al., 1995, J. Virol. 69:4471-4483.
Wang et al., 1993, Proc. Natl. Acad. Sci. USA 90:4156-4160.
Whitbeck et al., 1997, J. Virol. 71:6083-6093.
Wright et al., 1992, Critical Rev. in Immunol. 12(3,4):125-168.
Chan et al., 1985, J. Exp. Med., 162:1304-1318.
Long et al., 1984, Infection and Immunity, 37:761-764.

Affiliated with

Also associated with

Rating

Soluble herpesvirus glycoprotein complex vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Soluble herpesvirus glycoprotein complex vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble herpesvirus glycoprotein complex vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-958968